Mahan L C, McKernan R M, Insel P A
Annu Rev Pharmacol Toxicol. 1987;27:215-35. doi: 10.1146/annurev.pa.27.040187.001243.
Despite considerable evidence that changes in number of adrenergic receptors can occur under various conditions, knowledge of the mechanisms mediating these changes is still rudimentary. As discussed, indirect approaches emphasizing the kinetics of receptor turnover have been the principal means of investigation. These indirect methods, which depend on the ability of a radioligand to detect the receptors, are limited by several factors. Even so, the data obtained using indirect approaches, in particular on various model systems in cell culture, lead to several conclusions: Both alpha 1- and beta-adrenergic receptors are metabolized rather slowly in vitro under basal conditions, in the absence of exposure to agonists. Typical half-lives are greater than 20 hr, a turnover that is slower than that of several other classes of neurotransmitter and hormone receptors (9, 10, 12, 16). Moreover, alpha 1-adrenergic receptors and beta-adrenergic receptors can have substantially different half-lives, even when expressed on the same cell. In view of the relatively slow rate of disappearance of adrenergic receptors under basal conditions, settings in which receptor number increases are almost certainly to result from increases in one or more of the factors that contribute to the rate of receptor appearance on the plasma membrane. Treatment of cells with agonists markedly shortens the half-life of alpha 1- and beta-adrenergic receptors. This shortened half-life results primarily from an enhanced loss of receptors from the plasma membrane, and not from agonist-induced attenuation of receptor appearance. In fact, data acquired from studies of receptor recovery after agonist-induced down-regulation suggest that rates of receptor reappearance are markedly enhanced through either receptor recycling or an increase in receptor synthesis. Limited studies conducted in vivo yield qualitatively similar results to those observed in in vitro studies of the metabolism of adrenergic receptors. In general, adrenergic receptors in the CNS turn over more slowly than those in peripheral tissues. These conclusions help to highlight the many aspects of metabolism of adrenergic receptors that are as yet unknown, including identification and characterization of the cellular machinery responsible for receptor metabolism, elucidation of the molecular events that control metabolism, and assessment of how drugs and other factors influence these events. Future studies are likely to be based on the development of new methodology with antireceptor antibodies, receptor cDNA's, and improved morphological methods (autoradiography, immunohistochemistry, etc).(ABSTRACT TRUNCATED AT 400 WORDS)
尽管有大量证据表明,在各种情况下肾上腺素能受体的数量会发生变化,但介导这些变化的机制仍知之甚少。如前所述,强调受体周转动力学的间接方法一直是主要的研究手段。这些间接方法依赖于放射性配体检测受体的能力,受到几个因素的限制。即便如此,使用间接方法获得的数据,特别是在细胞培养中的各种模型系统上的数据,得出了几个结论:在基础条件下,即未暴露于激动剂时,α1和β肾上腺素能受体在体外的代谢相当缓慢。典型的半衰期大于20小时,这种周转率比其他几类神经递质和激素受体的周转率要慢(9, 10, 12, 16)。此外,即使在同一细胞上表达,α1肾上腺素能受体和β肾上腺素能受体的半衰期也可能有很大差异。鉴于在基础条件下肾上腺素能受体的消失速率相对较慢,受体数量增加的情况几乎肯定是由于一个或多个导致受体出现在质膜上的速率增加的因素所致。用激动剂处理细胞会显著缩短α1和β肾上腺素能受体的半衰期。这种缩短的半衰期主要是由于质膜上受体的损失增加,而不是激动剂诱导的受体出现减少。事实上,从激动剂诱导的下调后受体恢复的研究中获得的数据表明,通过受体再循环或受体合成增加,受体重新出现的速率显著提高。在体内进行的有限研究产生了与肾上腺素能受体代谢体外研究中观察到的结果在质量上相似的结果。一般来说,中枢神经系统中的肾上腺素能受体周转比外周组织中的要慢。这些结论有助于突出肾上腺素能受体代谢中许多未知的方面,包括负责受体代谢的细胞机制的确切身份和特征、控制代谢的分子事件的阐明,以及药物和其他因素如何影响这些事件的评估。未来的研究可能基于使用抗受体抗体、受体cDNA和改进的形态学方法(放射自显影、免疫组织化学等)开发新的方法。(摘要截断于400字)